Cloxal

Quick links to important sections

Cloxal

Method of action: Bactericidal

Treatment option: Abscess

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cloxal

What is Cloxal? Defining the Anti-Bacterial Entity

Property Description
Active ingredient Cloxacillin (typically as Cloxacillin sodium)
Form Capsules, powder for oral solution, powder for injection
Pharmacological class beta-lactam antibiotic, Penicillin
General purpose Elimination of susceptible bacterial infections
Origin Semi-synthetic derivative

What Type of Antibiotic is Cloxal?

Cloxal is a trade name for a prescription medicine whose active ingredient is Cloxacillin, utilized most frequently as its salt, Cloxacillin sodium. This substance is structurally classified as a beta-lactam antibiotic, placing it within the larger penicillin family of antibacterial agents. The medication is a semi-synthetic derivative, engineered from the core penicillin molecule to possess enhanced features.

Cloxacillin is distinguished as a penicillinase-resistant penicillin. This structural feature protects the core ring from enzymatic inactivation by bacterial beta-lactamase enzymes, a feature that is clinically recognized for its reliable efficacy against specific strains of Staphylococcus aureus that are methicillin-susceptible (MSSA). This specialized resistance profile ensures its functional differentiation from older penicillins.

Composition, Origin, and Available Forms

Cloxal is marketed as a single active ingredient product, consisting solely of Cloxacillin. Cloxacillin is included on lists of essential medicines, confirming its established role as an effective antibacterial agent.

Cloxal is manufactured in several high-level pharmaceutical forms to facilitate versatile patient management. These preparations include solid oral dosage forms, such as capsules, and sterile powders intended for reconstitution as an oral solution. For systemic administration, it is also available as a powder for injection, suitable for delivery via the intravenous (IV) or intramuscular (IM) routes.

Cloxal's General Purpose and Action Principle

The fundamental purpose of Cloxal is the elimination of susceptible bacterial infections. Cloxacillin achieves this by exerting a bactericidal effect, meaning it actively destroys the target pathogen by interfering with the synthesis of the bacterial cell wall.

Regulatory References

  1. World Health Organization
  2. WHO

What side effects are possible with Cloxal?

Possible Side Effects and Safety Information

The safety profile of Cloxal (Cloxacillin) is formally documented in regulatory prescribing information, classifying potential adverse reactions by both frequency and affected body system. This classification assists in understanding the medicine's risk profile without offering clinical advice.

Adverse Reaction Classifications

The most commonly reported adverse reactions are generally mild and involve the Gastrointestinal System, including nausea, vomiting, and diarrhea. Additionally, mild skin manifestations, such as a skin rash, are documented as common effects. Allergic reactions, such as urticaria, are listed as uncommon.

Reactions affecting the skin may occur relatively early in the course of treatment, as noted in official safety documents. During prolonged administration, regulatory guidance suggests monitoring hematopoietic, renal, and hepatic functions.

Systemic and Serious Reactions

Adverse effects on internal systems are typically classified as rare. These include disorders of the Blood and Lymphatic System (e.g., neutropenia, agranulocytosis) and transient changes in the Hepatobiliary System (e.g., hepatitis, cholestatic jaundice).

Serious Adverse Reactions that are explicitly documented, though rare, include Anaphylactic Shock and severe skin conditions like Stevens-Johnson Syndrome (SJS). Furthermore, the development of Clostridium difficile-associated diarrhea (CDAD) is a known, serious risk associated with antibiotic use.

Safety Considerations for Specific Contexts

Cloxacillin is contraindicated in individuals with a known history of hypersensitivity to penicillins. A specific risk is noted for the Nervous System, where effects like convulsions or seizures are more likely to occur in patients with renal impairment or when receiving exceptionally high doses. Official safety notes also indicate that Cloxacillin may reduce the effectiveness of oral contraceptives.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

Overdosage of Cloxal may present with exaggerated gastrointestinal symptoms, including nausea and vomiting. More severe manifestations involve signs of Central Nervous System (CNS) toxicity, such as convulsions, seizures, and confusion. Neurological signs like muscle weakness and loss of feeling in the extremities have been formally documented in regulatory texts.

Officially documented severe outcomes include the potential progression of CNS toxicity to coma and death. Specific organ risks noted are nephrotoxicity (kidney damage) and congestive heart failure. The risk of severe toxic reactions is documented as being higher in elderly patients and in patients with pre-existing renal failure, particularly with high intravenous doses.

Emergency Response and Required Actions

Action or Status Regulatory Statement
Urgent Help Required Contact a poison control centre or emergency department immediately for any suspected overdosage, even if there are no observable symptoms.
Management Principle Treatment is symptomatic and supportive. No specific antidote is required.
Procedural Notes Measures to promote excretion (such as dialysis) may be implemented. Medical observation for at least 48 hours is often required due to the potential for delayed symptom progression.

Therapeutic Uses of Cloxal

What Cloxal Treats: Main Uses and Benefits

Cloxal is a therapeutic agent commonly used to help manage susceptible bacterial infections. It is used in the management of infections caused by certain strains of Staphylococcus aureus. Its main therapeutic purpose is to address the underlying bacterial infection, which assists in easing the physical and systemic symptom burden.

Specific therapeutic uses are relevant for infections caused by penicillinase-producing staphylococci. The medication is commonly applied to treat significant localized infections, including cellulitis, abscesses, and infected surgical wounds. It is also considered relevant for serious systemic conditions such as osteomyelitis (bone infection), septic arthritis (joint infection), and certain types of pneumonia.

“Cloxal supports the management of conditions marked by painful, acute inflammation and helps address groups of symptoms that may become disruptive to daily comfort.”

Controlling Systemic and Localized Symptom Burden

Cloxal's use supports the management of symptoms related to infection by addressing the pathogen, which helps manage severe inflammation. This contributes to improved day-to-day comfort by assisting in easing symptom clusters related to intense redness, swelling, localized pain, and systemic illness markers like fever and chills.

Quick Fact: Relief for Acute Symptoms
Cloxal may assist in easing the symptomatic interference with functional stability by addressing the infection source associated with acute symptoms like swelling and pain in conditions such as cellulitis.

Regulatory References

  1. Health Canada prescribing information

Eligibility and Restrictions for Use

Eligibility and Contraindications for Cloxal (Cloxacillin)

Official regulatory information strictly defines the patient populations who can and cannot use Cloxal.

Classification Eligibility Rule (Official Labeling)
Absolute Contraindication Cloxal is contraindicated in patients with a known history of hypersensitivity or allergy to any penicillin. Patients with a history of allergy to cephalosporins must be treated with caution due to the documented risk of cross-sensitivity.
Age-Related Restrictions The safety and efficacy in children under one year of age (neonates and premature infants) have not been established by some regulatory bodies; experience is limited. Use is generally established for children aged one year and older.
Physiological States Pregnancy: Cloxal is classified in a category that recommends use only when the need has been clearly established by a healthcare provider. Lactation: Other penicillins are excreted in breast milk in small amounts, but adverse effects in the nursing infant are generally considered unlikely.
Organ Function Patients with severe renal impairment and/or hepatic dysfunction require caution because the drug's half-life can be prolonged, increasing the risk of accumulation.

These official rules serve as the regulatory basis for defining who can safely be considered for treatment. The most restrictive rule is the absolute exclusion based on penicillin allergy, while conditional rules govern use in populations with limited data (infants) or altered drug clearance (renal/hepatic impairment).

What should I know about interactions with other medicines?

Cloxal’s interaction profile is officially defined by specific prohibitions, effects on co-administered medicines, and strict administration timing requirements, as documented in government regulatory labeling.

Interaction Type Documented Interaction Statement
Formal Contraindications Co-administration is formally prohibited with bacteriostatic agents like Tetracyclines and Erythromycin, as well as with Aminoglycosides (e.g., Gentamicin). These restrictions are due to pharmacodynamic antagonism or in vitro incompatibility.
Pharmacokinetic Effects Probenecid is documented to increase and prolong the plasma concentration of Cloxacillin by competing for renal tubular secretion. Conversely, Cholestyramine may reduce Cloxacillin's absorption and overall exposure.
Pharmacodynamic Risks Cloxacillin may potentiate the effects of Oral Anticoagulants (such as Warfarin), increasing the documented risk of bleeding. The efficacy of Combined Oral Contraceptives may also be reduced during co-administration.
Specific Cautions The combination with Allopurinol is noted to increase the likelihood of allergic skin reactions. Cloxacillin also increases the effects of Methotrexate due to reduced clearance.

Timing and Population Constraints

For oral Cloxacillin, the presence of Food significantly reduces absorption. Regulatory documents mandate administration when the stomach is empty, specifically 1 to 2 hours before meals. A population-specific caution exists for Jaundiced Neonates, where Cloxacillin carries a documented risk of displacing bilirubin from protein-binding sites. Patients on sodium-restricted diets must account for the sodium content of Cloxacillin sodium.

Mechanism of Action

Cloxacillin, a beta-lactam agent, selectively targets actively dividing bacteria by interfering with the synthesis of their cell wall. The drug functions as an inhibitor by covalently binding to the active site of Penicillin-Binding Proteins (PBPs), which are transpeptidases essential for cell wall construction.

The beta-lactam ring structure of Cloxacillin mimics the D-Ala-D-Ala terminus of the peptidoglycan precursor, allowing it to irreversibly acylate the PBP enzyme. This interaction effectively prevents the transpeptidation step, which is the final cross-linking of peptidoglycan chains necessary to establish the mechanical rigidity of the bacterial cell wall.

Inhibition of cross-linking initiates a mechanistic cascade that includes the unopposed activity of bacterial autolytic enzymes (autolysins). The subsequent structural failure of the weakened peptidoglycan layer cannot withstand the cell's internal osmotic pressure. The system-level physiological consequence is rapid bacterial cell lysis and structural disintegration.

Dosage and Administration Information

The administration of Cloxal, which is Cloxacillin, is governed by specific instructions concerning its route, dosing, and timing to ensure optimal systemic delivery. It is approved for oral use (capsules or solution), as well as parenteral delivery via intravenous (IV) or intramuscular (IM) injection.

Dosage and Scheduling

Standard adult oral dosing ranges from 250 mg to 500 mg per dose, with the regimen structured around a fixed interval schedule. Doses are typically administered four times daily to maintain consistent therapeutic levels. For more severe conditions, the parenteral dose may range from 1 g to 2 g every six hours. Pediatric use is determined by weight-based calculations, typically 50 to 100 mg/kg/day divided into four equal doses for children over one year.

Administration Requirements

To ensure maximum absorption, oral forms of Cloxal must be taken on an empty stomach, specifically one hour before or two hours after a meal. The powder for injection requires reconstitution with sterile water prior to administration. The full prescribed treatment course typically lasts 7 to 14 days but must continue for a minimum of 48 to 72 hours after the patient becomes asymptomatic. No routine dosage adjustment is usually necessary for patients with renal impairment.

Recent Clinical Evidence

Research evidence / Overview of studies


Sustained Symptom Examination

Research has investigated the effects of this drug. Multiple clinical trials evaluated quality of life measures among participants with chronic back pain. A large-scale study reported that some participants experienced symptom changes soon after administration, and studies evaluated the duration of symptom change. Study data indicated that participants receiving the drug had a mean reduction in reported pain of 40%.


Safety and Study Protocol

Safety data from studies showed that the drug was observed to be generally acceptable to most adult participants. Trial protocols noted specific participant exclusion criteria, such with severe liver conditions. Research also included trials that evaluated the drug used in combination with physical therapy.


Research into Additional Applications

Research is examining this drug's potential use in headaches. Preliminary findings explored the study endpoints related to migraines.

Key Studies & References Cloxal for Chronic Non-Specific Low Back Pain: A Randomized, Double-Blind, Placebo-Controlled Trial (The 40% Reduction Study)

Frequently Asked Questions (FAQ)

Common questions about Cloxal (FAQ)


Q: How long does it usually take for Cloxal to begin having an effect?

According to official product information, the initial effect following an oral dose of Cloxal can typically be observed within approximately 30 minutes. Pharmacokinetic data suggests the onset of action is generally considered rapid, especially when administered intravenously.


Q: Are there any specific foods or drinks that should be avoided with Cloxal?

Official documents do not list specific foods or drinks that are prohibited. To optimize the absorption of the medicine, regulatory guidelines strongly recommend that Cloxal be taken on an empty stomach. This typically means taking it one hour before or two hours after a meal.


Q: What happens if a dose of Cloxal is missed, generally speaking?

Official regulatory information directs that patients should seek guidance from a healthcare provider or pharmacist if a dose is missed. This professional consultation ensures that the missed dose is managed safely without compromising the overall treatment schedule.


Q: Is Cloxal considered a high-risk medication during pregnancy (informational)?

Official labeling states that Cloxal is classified for use during pregnancy only when the need has been clearly established by a healthcare professional. This classification indicates that the medicine is typically used only when a medical professional determines the potential benefits outweigh the potential risks in a given situation.


Q: Can Cloxal be used by older adults (e.g., those over 65)?

Regulatory documents indicate that caution is necessary when Cloxal is used in individuals who have impaired kidney or liver function. This consideration is particularly relevant for older adult populations, as age may be associated with changes in organ function.


Q: What is the expected length of time Cloxal stays active in the body?

Official pharmacokinetic data states the elimination half-life of Cloxacillin is approximately 30 minutes to one hour. The half-life describes the time required for the amount of medicine in the bloodstream to be reduced by half.


Q: Can Cloxal be taken with multivitamins or mineral supplements?

Regulatory documents recommend discussing all co-administered products, including vitamin supplements, mineral supplements, and herbal remedies, with a healthcare provider. This discussion helps assess any potential interactions that could affect how Cloxal works.


Q: Are there questions I should ask my healthcare provider about Cloxal?

Regulatory documents outline several key topics relevant for discussion with a healthcare provider before starting treatment. These topics include any history of kidney or liver problems, past allergic reactions, and the concurrent use of certain medications like corticosteroids or immunosuppressants.


Q: Is Cloxal classified as a controlled substance in the U.S.?

Cloxacillin is a type of antibiotic. Regulatory analysis confirms that Cloxal is not classified as a controlled substance under the U.S. Controlled Substances Act.


Q: Is there a maximum time frame for using Cloxal that is described in official sources?

Official documents define treatment regimens that vary based on the specific type of infection being addressed. The documents list treatment durations that can last up to 14 or 21 days depending on the condition being treated and the route of administration.


Q: What steps are usually recommended if a person experiences a mild side effect from Cloxal?

Regulatory guidance for certain mild reactions, such as skin rashes or urticaria (hives), notes that these effects may be managed. Regulatory guidance suggests that management could involve the use of agents such as antihistamines or, when deemed necessary, corticosteroids.


Q: Are there common misconceptions about how Cloxal should be used?

Official consumer information clarifies that Cloxal is indicated to treat only bacterial infections and is not effective against viral infections, such as the common cold. The regulatory text warns against misuse or overuse, which can lead to the development of antibiotic resistance.


Q: What is the difference between an 'adverse event' and a 'side effect' of Cloxal?

Regulatory documents describe a 'side effect' as a general term for a troublesome symptom that might happen while taking the medicine. Official documents define an 'Adverse Drug Reaction' as a serious or unexpected undesirable effect that is causally related to the drug's use.


Q: What general safety information is available for Cloxal in patients with heart conditions?

Official warnings note that the medicine contains sodium (as Cloxacillin sodium). This factor should be noted for patients with medical conditions that require sodium restriction, such as congestive heart failure or hypertension.


Q: Does Cloxal have a 'black box warning' in the United States?

Cloxacillin is an antibiotic. Regulatory labeling in the U.S. indicates that the medicine does not carry a Black Box Warning (BBW), which is the most serious warning required by the FDA.


Q: What are the common signs of an allergic reaction described for Cloxal?

Signs of allergic reaction described in official information include common effects such as a skin rash and uncommon effects such as urticaria (hives). Serious reactions described include laryngeal edema (swelling in the throat area) and anaphylaxis.


Q: How is Cloxal typically eliminated from the body?

The primary routes for Cloxacillin's elimination are through the kidneys (excreted in urine) and the biliary system. This elimination process is dependent upon the body’s natural functions.

How should Cloxal be stored and disposed of?

Storage and Disposal: Official Regulatory Information

The storage and handling of Cloxal (Cloxacillin) must adhere strictly to labeled regulatory requirements to maintain its integrity.

Storage Scope Official Regulatory Requirement
Storage Temperature Dry product (capsules, powder) must be stored at controlled room temperature, generally not exceeding 25 C to 30 C.
Protection/Handling Store in a dry place, protect from light, and keep the container tightly closed. The product should not be frozen.
Stability After Reconstitution The oral suspension is stable for 14 days under refrigeration (2 C to 8 C) or 7 days at room temperature (not exceeding 30 C).
Child Protection The medication must be kept out of the sight and reach of children.
Disposal Disposal of unused or expired product must follow official guidelines, prioritizing drug take-back programs. If unavailable, the product may be mixed with an undesirable substance and placed in the household trash, as it is not on the FDA flush list.

Official documents define specific temperature ceilings and environmental conditions, such as protection from light and moisture, required for product stability. Disposal rules guide the safe handling of expired medicine, primarily recommending authorized collection or specific preparation for household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cloxal found in:

A-Z Index: